Hyundai Bioscience top holder CnPharm cuts shares under pledge contracts to 7.76% from 7.92%

Bitget2026/09/30 08:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

CnPharm filed an amended large-shareholding report for Hyundai Bioscience, citing changes to stock-pledge contracts.
Total stake held steady at 11,546,001 shares, or 11.96%, as of Sept. 30.
Voting rights also remained unchanged at 9,746,797 votes, or 10.10%.
Shares subject to major contracts fell to 7,486,806 shares, or 7.76%, from 7,641,806 shares, or 7.92%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hyundai Bioscience Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930000523), on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Hyundai Bioscience top holder CnPharm cuts shares under pledge contracts to 7.76% from 7.92%

You may also like

Crypto prices